Please enjoy! This is a Webinar on cell line development and more specifically our high titer producing platform. We wanted to show companies in the area our technical expertise as a CDMO! (Find a hyperlink attached below.)
This webinar will explore BIB’s optimized cell line development platform, tailored to meet the growing demand for monoclonal antibodies. Throughout the session, attendees will gain insights into:
The global antibody market trends and growth projections through 2030
Challenges in large-scale antibody manufacturing and BIB’s innovative solutions
Our proprietary mammalian vector system and host cell line
A streamlined process delivering high-yielding stable antibody or protein clones within just 3 months
A preview of the breakthrough knockout host cell line capable of producing 7 to 10 gm/L of monoclonal antibodies
Whether you’re facing complexities in manufacturing efficiency, cost constraints, or striving for higher titers, this webinar will equip you with actionable strategies to overcome these challenges. Don’t miss this opportunity to learn from a leader in the field and explore project opportunities with BIB.
High-Producing Mammalian CLD Platform – Boston Institute of Biotechnology (bostonbib.com)